Skip Navigation

The Pandemic’s Continued Strain On Labor And Other Key Takeaways From The Diversion Trends Report

Blog

The Pandemic’s Continued Strain On Labor And Other Key Takeaways From The Diversion Trends Report

Kit Check recently released its 2022 Diversion Trends Report. In the report, Kit Check analyzed…

Blog

Kit Check Releases New Medication Pricing Information Function as First Step Towards Further Product Integration.

By Hannah Kanfer Kit Check recently released a new feature that integrates medication pricing information…

Blog

New Bill Will Help Prevent Opioid Deaths by Making Opioid Overdose Medications More Accessible. 

By Hannah Kanfer   The opioid epidemic has been a long battle in the United…

Blog

Early Recognition and Culture of Safety, both Vital to Catching and Preventing Diversion.

Kit Check’s top takeaways from NADDI 2022. By Hannah Kanfer This past week, Kit Check…

Blog

The Evolution of 340B and the Challenges it Faces; is Technology the Answer?

The Evolution of 340B and the Challenges it Faces; is Technology the Answer?  By Hannah…

Blog

Kit Check RFID Helps Reading Hospital with its COVID-19 Vaccine Roll Out

While the newly FDA approved COVID-19 vaccines from Pfizer and Moderna are a welcome reprieve …

Blog

Seeing More, Achieving More with Bluesight

Has your team outgrown your current tools and software in the hospital pharmacy? It’s time …

Blog

Diversion Quarterly — Q3 2020

Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly…

Blog

Introducing Beju Shah, Kit Check’s New Director of Clinical Solutions

Beju’s career thus far has provided him a unique set of skills – he’s equipped…

Blog

DoseID in Healthcare Tech Outlook

Kit Check is a founding member of DoseID, the pharmaceutical industry’s first consortium around best…

1 of 15